SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-070716
Filing Date
2023-08-25
Accepted
2023-08-25 08:00:22
Documents
3
Period of Report
2023-08-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184154-6k_ysbiopharma.htm 6-K 15260
2 YS BIOPHARMA ANNOUNCES OFFICERS' SHARE PURCHASE ea184154ex99-1_ysbiopharma.htm EX-99.1 11582
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5453
  Complete submission text file 0001213900-23-070716.txt   35704
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 861089202086
YS Biopharma Co., Ltd. (Filer) CIK: 0001946399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41598 | Film No.: 231203815
SIC: 2834 Pharmaceutical Preparations